Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial
DiscussionThe FAAC trial was approved by the Ethics Committee of EST III with approval number 19.05.08. The FAAC trial is the first randomized controlled trial comparing landiolol to amiodarone for PoAF after cardiac surgery. In case of higher rate of reduction with landiolol, this beta-blocker could be the drug of choice used in this context as to reduce the need for anticoagulant therapy and reduce the risk of complications of anticoagulant therapy for patients with a first episode of postoperative atrial fibrillation after cardiac surgery.Trial registrationClinicalTrials.gov NCT04223739. Registered on January 10, 2020. (Source: Trials)
Source: Trials - May 25, 2023 Category: Research Source Type: clinical trials
A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Condition: Atrial Fibrillation New Onset Intervention: Other: Prophylactic amiodarone and posterior pericardiotomy Sponsor: Massachusetts General Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2023 Category: Research Source Type: clinical trials
Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone
Condition: Post Operative Atrial Fibrillation Intervention: Combination Product: CardiaMend with the Addition of Amiodarone Sponsors: WakeMed Health and Hospitals; Helios Cardio Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials
